<VariationArchive VariationID="204246" VariationName="NM_012203.1(GRHPR):c.[84-8_84-5delCCCC;84-13_84-12delCC]" VariationType="Haplotype" Accession="VCV000204246" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2015-07-21" MostRecentSubmission="2015-07-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Haplotype VariationID="204246" NumberOfChromosomes="1">
      <SimpleAllele AlleleID="200619" VariationID="242572">
        <GeneList>
          <Gene Symbol="GRHPR" FullName="glyoxylate and hydroxypyruvate reductase" GeneID="9380" HGNC_ID="HGNC:4570" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>9p13.2</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37422435" stop="37439494" display_start="37422435" display_stop="37439494" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37422706" stop="37436985" display_start="37422706" display_stop="37436985" Strand="+" />
            </Location>
            <OMIM>604296</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_012203.2(GRHPR):c.84-8_84-5del</Name>
        <CanonicalSPDI>NC_000009.12:37424836:CCCC:</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>9p13.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37424837" stop="37424840" display_start="37424837" display_stop="37424840" variantLength="4" positionVCF="37424836" referenceAlleleVCF="TCCCC" alternateAlleleVCF="T" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37424834" stop="37424837" display_start="37424834" display_stop="37424837" variantLength="4" positionVCF="37424833" referenceAlleleVCF="TCCCC" alternateAlleleVCF="T" />
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.37424834_37424837del" Assembly="GRCh37">
              <Expression>NC_000009.11:g.37424834_37424837del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.37424837_37424840del" Assembly="GRCh38">
              <Expression>NC_000009.12:g.37424837_37424840del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008135.1" sequenceAccession="NG_008135" sequenceVersion="1" change="g.7128_7131del">
              <Expression>NG_008135.1:g.7128_7131del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_012203.2" sequenceAccession="NM_012203" sequenceVersion="2" change="c.84-8_84-5del" MANESelect="true">
              <Expression>NM_012203.2:c.84-8_84-5del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-03-01" DateCreated="2023-01-26" MostRecentSubmission="2024-04-05" NumberOfSubmissions="2" NumberOfSubmitters="2">
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description>Conflicting classifications of pathogenicity</Description>
            <Explanation DataSource="ClinVar" Type="public">Uncertain significance(1); Likely benign(1)</Explanation>
            <Comment DataSource="ClinVar" Type="public">Uncertain significance(1); Likely benign(1)</Comment>
            <DescriptionHistory Dated="2023-12-15">
              <Description>Likely benign</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2023-01-31">
              <Description>no classification for the single variant</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="1588" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2365" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">OXALOSIS II</ElementValue>
                    <XRef Type="MIM" ID="260000" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Primary hyperoxaluria type 2</ElementValue>
                    <XRef ID="MONDO:0009824" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Primary hyperoxaluria, type II</ElementValue>
                    <XRef ID="Primary+hyperoxaluria+type+2/5948" DB="Genetic Alliance" />
                    <XRef ID="40951006" DB="SNOMED CT" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Oxalosis 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Glyoxylate reductase/hydroxypyruvate reductase deficiency</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Glyceric aciduria</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">D-glycerate dehydrogenase deficiency</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">PH2</ElementValue>
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">HP2</ElementValue>
                    <XRef Type="MIM" ID="260000" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                    <XRef ID="GTR000507682" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000561372" DB="Genetic Testing Registry (GTR)" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Primary hyperoxaluria type 2 (PH2), caused by deficiency of the enzyme glyoxylate reductase/hydroxypyruvate reductase (GR/HPR), is characterized by recurrent nephrolithiasis (deposition of calcium oxalate in the renal pelvis/urinary tract), nephrocalcinosis (deposition of calcium oxalate in the renal parenchyma), and end-stage renal disease (ESRD). After ESRD, oxalosis (widespread tissue deposition of calcium oxalate) usually develops. Symptom onset is typically in childhood.</Attribute>
                    <XRef ID="NBK2692" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="2836" />
                    <XRef ID="2836" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301742</ID>
                    <ID Source="BookShelf">NBK2692</ID>
                  </Citation>
                  <XRef ID="416" DB="Orphanet" />
                  <XRef ID="93599" DB="Orphanet" />
                  <XRef ID="C0268165" DB="MedGen" />
                  <XRef ID="MONDO:0009824" DB="MONDO" />
                  <XRef Type="MIM" ID="260000" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="204246" DB="ClinVar" />
          <XRef Type="rs" ID="180177320" DB="dbSNP" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD)" />
          <AlleleFrequency Value="0.00005" Source="Exome Aggregation Consortium (ExAC)" />
        </AlleleFrequencyList>
      </SimpleAllele>
      <SimpleAllele AlleleID="200618" VariationID="242573">
        <GeneList>
          <Gene Symbol="GRHPR" FullName="glyoxylate and hydroxypyruvate reductase" GeneID="9380" HGNC_ID="HGNC:4570" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>9p13.2</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37422435" stop="37439494" display_start="37422435" display_stop="37439494" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37422706" stop="37436985" display_start="37422706" display_stop="37436985" Strand="+" />
            </Location>
            <OMIM>604296</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_012203.2(GRHPR):c.84-13_84-12del</Name>
        <CanonicalSPDI>NC_000009.12:37424830:CCC:C</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>9p13.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37424831" stop="37424832" display_start="37424831" display_stop="37424832" variantLength="2" positionVCF="37424830" referenceAlleleVCF="TCC" alternateAlleleVCF="T" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37424828" stop="37424829" display_start="37424828" display_stop="37424829" variantLength="2" positionVCF="37424827" referenceAlleleVCF="TCC" alternateAlleleVCF="T" />
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.37424829_37424830del" Assembly="GRCh37">
              <Expression>NC_000009.11:g.37424829_37424830del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.37424832_37424833del" Assembly="GRCh38">
              <Expression>NC_000009.12:g.37424832_37424833del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008135.1" sequenceAccession="NG_008135" sequenceVersion="1" change="g.7123_7124del">
              <Expression>NG_008135.1:g.7123_7124del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_012203.2" sequenceAccession="NM_012203" sequenceVersion="2" change="c.84-13_84-12del" MANESelect="true">
              <Expression>NM_012203.2:c.84-13_84-12del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_012203.1" sequenceAccession="NM_012203" sequenceVersion="1" change="c.84-13_84-12delCC">
              <Expression>NM_012203.1:c.84-13_84-12delCC</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </GermlineClassification>
          <SomaticClinicalImpact NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </SomaticClinicalImpact>
          <OncogenicityClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </OncogenicityClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="204246" DB="ClinVar" />
          <XRef Type="rs" ID="796052080" DB="dbSNP" />
        </XRefList>
      </SimpleAllele>
      <Name>NM_012203.1(GRHPR):c.[84-8_84-5delCCCC;84-13_84-12delCC]</Name>
      <VariationType>Haplotype</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_012203.1:c.[84-8_84-5delCCCC;84-13_84-12delCC]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA352243" DB="ClinGen" />
      </XRefList>
    </Haplotype>
    <RCVList>
      <RCVAccession Title="NM_012203.1(GRHPR):c.[84-8_84-5delCCCC;84-13_84-12delCC] AND Primary hyperoxaluria, type II" Accession="RCV000186453" Version="3">
        <ClassifiedConditionList TraitSetID="1588">
          <ClassifiedCondition DB="MedGen" ID="C0268165">Primary hyperoxaluria, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-11-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-11-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-07-21" MostRecentSubmission="2015-07-21">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14635115</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.uclh.nhs.uk/OurServices/ServiceA-Z/PATH/PATHBIOMED/CBIO/Documents/GRHPR%20mutation%20database.pdf</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="1588" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2365" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OXALOSIS II</ElementValue>
                <XRef Type="MIM" ID="260000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oxalosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glyoxylate reductase/hydroxypyruvate reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glyceric aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">D-glycerate dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Primary hyperoxaluria, type II</ElementValue>
                <XRef ID="Primary+hyperoxaluria+type+2/5948" DB="Genetic Alliance" />
                <XRef ID="40951006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Primary hyperoxaluria type 2</ElementValue>
                <XRef ID="MONDO:0009824" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HP2</ElementValue>
                <XRef Type="MIM" ID="260000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Primary hyperoxaluria type 2 (PH2), caused by deficiency of the enzyme glyoxylate reductase/hydroxypyruvate reductase (GR/HPR), is characterized by recurrent nephrolithiasis (deposition of calcium oxalate in the renal pelvis/urinary tract), nephrocalcinosis (deposition of calcium oxalate in the renal parenchyma), and end-stage renal disease (ESRD). After ESRD, oxalosis (widespread tissue deposition of calcium oxalate) usually develops. Symptom onset is typically in childhood.</Attribute>
                <XRef ID="NBK2692" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000507682" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561372" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2836" />
                <XRef ID="2836" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301742</ID>
                <ID Source="BookShelf">NBK2692</ID>
              </Citation>
              <XRef ID="416" DB="Orphanet" />
              <XRef ID="93599" DB="Orphanet" />
              <XRef ID="C0268165" DB="MedGen" />
              <XRef ID="MONDO:0009824" DB="MONDO" />
              <XRef Type="MIM" ID="260000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="443560" SubmissionDate="2014-11-27" DateLastUpdated="2015-07-21" DateCreated="2015-07-21">
        <ClinVarSubmissionID localKey="NM_012203.1:c.[84-8_84-5delCCCC;84-13_84-12delCC]" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000239808" DateUpdated="2015-07-21" DateCreated="2015-07-21" Type="SCV" Version="1" SubmitterName="Clinical Biochemistry Laboratory, Health Services Laboratory" OrgID="118451" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-11-27">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">14635115</ID>
            </Citation>
            <Citation>
              <URL>http://www.uclh.nhs.uk/OurServices/ServiceA-Z/PATH/PATHBIOMED/CBIO/Documents/GRHPR%20mutation%20database.pdf</URL>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <Haplotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="GRHPR" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_012203.1:c.84-8_84-5delCCCC</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="GRHPR" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_012203.1:c.84-13_84-12delCC</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <Name>NM_012203.1:c.[84-8_84-5delCCCC;84-13_84-12delCC]</Name>
        </Haplotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Primary hyperoxaluria, type II</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="443560" TraitType="Disease" MappingType="Name" MappingValue="Primary hyperoxaluria, type II" MappingRef="Preferred">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

